GlobalData Archives - Express Pharma

Paratek Phase IIb data shows omadacycline’s potential to address unmet needs in NTM treatment, says GlobalData

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Diagnosed prevalent cases of primary open-angle glaucoma to reach 10 mn in 7MM by 2033

Bladder cancer diagnosed incident cases across 8MM to reach 0.34 mn in 2033

Cardiovascular benefits can increase Rybelsus’ competitiveness over other oral GLP-1RAs

Diagnosed incident cases of sepsis set to reach 9.52 mn by 2033

COPD market to reach $30.8 billion in 7MM by 2033: GlobalData

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData

Global leaders unite to combat AMR: targets set at UNGA are urgently needed: GlobalData